Current Indications and Future Landscape of Bispecific Antibodies for the Treatment of Lung Cancer

Current Indications and Future Landscape of Bispecific Antibodies for the Treatment of Lung Cancer

Bispecific antibodies are a promising type of therapy for the treatment of cancer due to their ability to simultaneously inhibit different proteins playing a role in cancer progression. The development in lung cancer has been singularly intense because of the increasingly vast knowledge of the under...

Full description

Bibliographic Details
Main Authors: Hugo Arasanz, Luisa Chocarro, Leticia Fernández-Rubio, Ester Blanco, Ana Bocanegra, Miriam Echaide, Ibone Labiano, Ana Elsa Huerta, Maria Alsina, Ruth Vera, David Escors, Grazyna Kochan
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:International Journal of Molecular Sciences
Subjects:
lung cancer
bispecific
nanobodies
NSCLC
SCLC
targeted therapies
Online Access:https://www.mdpi.com/1422-0067/24/12/9855

Internet

https://www.mdpi.com/1422-0067/24/12/9855

Similar Items